dc.identifier.citation | 1. Erol, A. (2007). The Functions of PPARs in Aging and Longevity. PPAR Research Hindawi, Volume (2007), 1-10. 2. Grygiel-Gorniak, B.. 2014. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review. Nutrition Journal, volume 13 (1d7), 1-10. 3. Gupta, V. K. dan Sharma, S. K. 2006. Plants as Natural Antioxidant. Natural Product Radiance, Volume 5 (4), 326-334. 4. Hallakou S, Doare L, Foufelle F. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes, Volume 46, 1393–1399. 5. Kalim, H., Murniati, A., Zulaikah, S., Ma’rufah, Triastyanto, N., Pradana, W., Endaharti, A. T. dan Suryana, P. 2014. Pioglitazone Increase PPAR-γ Expression, Decrease MMP-9, MMP-13, VEGF, NO and TNF-α Secretion in IL-1β-induced Chondrocyte. IOSR Journal of Dental and Medical Sciences, IOSR Journal of Dental and Medical Sciences, Volume 13, 1-7. 6. Kennedy, S. R., Loeb, J. A., dan Herr, A. J. 2011. Somatic Mutations in Aging, Cancer, and Neurodegenaratif. Mechanism of Aging and Development, volume 133 (4), 118-126 7. Kota, Bhavani P., Huang, Tom Hsun-Wei, & Roufogalis, Basil D. 2005. An Overview on Biological Mechanism of PPARs. Pharmacological Research,Volume 51, 85-94. 8. Larsen, T. M.,Toubro, S. dan Astrup, A. 2003. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?. International Journal of Obesity, Volume 27, 147–16. 9. Laskowski R. A., Swindells M.B.. 2011. LigPlot + : multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model., 51, 2778-2786. 10. Pangastuti,A., Amin, I. F., Amin, A. Z., dan Amin, M. 2016. Natural Bioactive Compound From Moringa oleifera Against Cancer Based on In Silico Screening. Jurnal Teknologi (Sciences & Engineering, Volume 78:5, 315–318 11. Saptarini, N. M., Saputri, F. A., & Levita, J. 2014. Molecular Modeling Study of PPARγ Agonists: Dehydro-Di-Isoeugenol, Macelignan, Pioglitazone, Netoglitazone, and Rosiglitazone as Antidiabetic Drugs. International Journal of Chemistry, Volume 6 (2), 48-55. 12. Sharafzadeh, S. 2013. Medical Plants as Anti-Ageing Materials: A Review. Global Journal of Medicinal Plant Research, Volume 1(2), 234-236. 13. Uppenberg, J., Svensson, C., Jaki, M., Bartilsson, G., Jendeberg, L., & Berkenstam, A. 1998. Crystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPAR-γ. The Journal of Biological Chemistry, Volume 273 (47), 31108–31112. 14. Vina, J., Borras, C., dan Miquel, J. (2007). Theories of Ageing. IUBMB Life, Volume 59 (4-5), 249-248. 15. Yang, HC, Deleuze, S., Zuo, Y., Potthoff, S. A., Ma, LJ, dan Fogo, A.B. 2009. The PPARγ Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury. J Am Soc Nephrol, volume 20, 23802388. 16. http://www.rcsb.org 17. http://services.mbi.ucla.edu/SAVES/ 18. http://mobyle.rpbs.univ-paris-diderot.fr/cgi-bin/portal.py#forms | in_ID |